Volumes : Issues : Articles

Cancer Watch 2000
Cancer Watch 2001
Cancer Watch 2002
Cancer Watch 2003
Cancer Watch 2004
Cancer Watch 2005
Cancer Watch 2006
Cancer Watch 2007
Cancer Watch 2008
Cancer Watch 2009
Cancer Watch 2010
Cancer Watch 2011
Cancer Watch 2012

CW October 2005

Volume 14
Issue Number 10
October 2005
ISSN 10593802

FDA Approves Anastrozole for Certain Breast Cancer Patients

The US Food and Drug Administration (FDA) has granted full approval status to anastrozole (Arimidex®, Astra Zeneca) for the adjuvant treatment of hormone receptor-positive early breast cancer in postmenopausal women.
Go to Previous Page
Go to Next Page

Source & Additional Reading

European Journal of Cancer, August 2005.

Purchase Downloadable Full-text PDF of Article: $10.00

Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details.

Download Complete Issue CW October 2005

Purchase Downloadable Full-text PDF of Complete Issue: $20.00

<< Go Back to CW October 2005